The screenless strap that sells recovery as a subscription
HQ: Boston, MA, United States | Founded: 2012 | Employees: Not disclosed in reviewed sources | Stage: Late-stage private; $10.1B valuation after a $575M Series G in March 2026; total funding above $950M | Website: https://www.whoop.com
WHOOP was founded in 2012 in Boston by Will Ahmed, John Capodilupo and Aurelian Nicolae. Ahmed, a Harvard undergraduate rower, was interested in how the body responds to training load and built the first strap around continuous heart-rate variability rather than step counting. The company's early customers were athletes and teams — it became a fixture in professional sports, college athletics and the military — and the screenless, always-on strap became its signature: no display, no notifications, just data and a daily recovery score.
The commercial model followed the product logic. Rather than selling hardware at a margin, WHOOP bundles the strap into a membership and charges annually, which aligns the company with retention and gives it recurring revenue. That model made the company a unicorn in 2020 ($100M at $1.2B), then a $3.6B company in 2021 after a $200M round led by SoftBank Vision Fund 2. Membership tiers now run from $199 to $359 a year, with the medical-grade MG tier at the top.
WHOOP 5.0 and WHOOP MG, launched in May 2025, were the biggest product step in the company's history: smaller sensors, up to 14-day battery, ECG and AFib detection cleared by the FDA, blood pressure insights, and a faster processor for on-device analytics. The company paired the hardware with software — WHOOP Coach, a generative AI assistant that answers questions about sleep, strain and recovery, and WHOOP Advanced Labs, which adds blood biomarker testing. WHOOP Unite packages the platform for employers, sports organisations and health systems, giving the company a second, less consumer-cyclical channel.
The March 2026 Series G was a validation round as much as a financing: $575M at a $10.1B valuation, led by Collaborative Fund, with a long list of institutional backers — 2PointZero Group, the Qatar Investment Authority, Mubadala, Abbott, Mayo Clinic, Macquarie Capital, Glade Brook, B-Flexion, IVP, Foundry, Accomplice, Affinity Partners, Promus Ventures and Bullhound Capital — plus athletes including Cristiano Ronaldo, LeBron James, Rory McIlroy, Reggie Miller, Niall Horan, Virgil van Dijk and Shane Lowry. WHOOP disclosed 2.5M members, bookings growth of 103% year over year, a bookings run rate of about $1.1B exiting 2025 and positive operating cash flow for the year — the first time it has been that specific about scale. The money funds U.S. growth and expansion across Europe, the GCC, Latin America and Asia, plus 600-plus planned hires in R&D and international operations.
WHOOP is the clearest example of a wearable company that chose subscription revenue over hardware margin, and it is now being rewarded for it. The strap has no screen, which sounds like a limitation until you see the economics: members pay $199 to $359 a year for coaching, analysis and hardware upgrades, so revenue recurs while hardware costs fall. That model produced 103% year-over-year bookings growth and a bookings run rate of roughly $1.1B exiting 2025, and it supported a $575M Series G at $10.1B in March 2026 — more than triple the $3.6B valuation of its 2021 round — led by Collaborative Fund with the Qatar Investment Authority, Abbott Laboratories and a roster of athlete investors from Cristiano Ronaldo to LeBron James.
Financially, the round came with an unusual disclosure for a private consumer company: WHOOP said 2025 was cash flow positive, on top of 103% bookings growth and a hiring plan for 600-plus roles. The product has also widened. WHOOP 5.0 and the medical-grade WHOOP MG, launched in May 2025, added blood pressure insights, ECG and AFib detection with FDA clearance, irregular-rhythm notifications and longer battery life, turning a recovery tracker into something closer to a preventive health device. WHOOP Advanced Labs added blood biomarker testing, WHOOP Coach put a generative AI coach on top of the data, and WHOOP Unite sells the same platform to employers, sports teams and health systems. That breadth matters because the consumer wearable market is crowded and cheap: Apple, Garmin and Oura all sell credible alternatives, and Whoop's answer is depth of physiological insight plus a clinical-grade feature set that a watch maker has to be careful about claiming.
The open questions are cost and proof. WHOOP spends heavily on athlete sponsorships, media and R&D, and it does not publish full financials — though it says 2025 was cash flow positive, profitability on a net basis has not been disclosed, so the Series G is capital to keep growing a subscription base that must eventually justify a $10.1B mark. Churn is the real adversary — a $239-a-year membership has to keep proving value after the novelty fades, and the company's expansion into blood testing and medical features raises both regulatory exposure and support costs. If it can convert its athlete credibility into a durable consumer health subscription, with employers and insurers paying part of the bill through WHOOP Unite, the valuation is defensible. If the market treats it as a fitness gadget with a recurring fee, the multiple compresses.
Browse: Home | Blog | About | All Startups A-Z | View full profile on StartupWiki